Since 2010, Inserm Transfert has been committed to quality management approach which have gradually been extended to all its activities in order to strengthen and adapt our standards continuously throughout the whole value chain.
We have been ISO 9001 v2015 certified since October 2018, for all the processes used to enhance the value of innovations from Inserm laboratories and its partners. Inserm Transfert remains engaged in maintaining and improving the satisfaction of its partners and clients while continuing to adapt to changes in its environment. This approach to quality management, which was initiated as part of a joint effort by all Inserm Transfert departments, is part of the operational management of all activities, implementing :
The quality policy applied by Inserm Transfert aims to ensure that our partners and clients (researchers, institutions and industrial partners) receive high-quality services, the best possible client relationships and the best advice in order to best meet their needs.
Our quality policy is expressed by implementing key operational processes in our mission, having the identification and qualification of the offer and opportunities as a starting point and the monitoring of projects and partnerships as an end point.
Inserm Transfert places customer satisfaction at the heart of the company's concerns, both at the management and employee levels.
In order to maintain and improve this satisfaction, Inserm Transfert has launched a campaign to measure customer (and partner) satisfaction in 2020.
During this period of exceptional health crisis, the Inserm Transfert teams have remained mobilized in order to maintain their activities and carry out their mission. It was therefore important for us to gather the opinion of our partners and clients (researchers and industrial partners) on 4 main subjects:
And in general, our support and expertise. This survey shows that :
In addition, 93% of the researchers who expressed themselves are globally satisfied with
The survey was also sent to our industrial partners, with a return rate of 14%, which does not allow us to exploit the results and identify a trend. However, the statistics show that, on average, 80% of the industrial partners who responded are satisfied with Inserm Transfert overall and recommend it.
Note : The survey was sent to 282 researchers and 77 industrial partners for a response rate of 23% (n=73 researcher returns and n=11 industrial returns)